血管抑素

Angiostatin, a potent angiogenesis inhibitor, has shown promise in preclinical studies for its ability to suppress tumor growth.
(Angiostatin是一种强大的血管生成抑制剂，在临前研究中因其能够抑制肿瘤生长而显示出前景。
Researchers have investigated the use of angiostatin as a potential therapeutic agent in treating cancer by blocking blood vessel formation.
研究人员正在研究将angiostatin作为一种治疗癌症的潜在药物，通过阻断血管形成。
In vitro experiments demonstrated that angiostatin effectively inhibited endothelial cell proliferation and migration, key processes in angiogenesis.
体外实验显示，angiostatin有效地抑制了内皮细胞的增殖和迁移，这是血管生成过程中的关键步骤。
The clinical trial of angiostatin for glioblastoma patients showed mixed results, but it highlighted the need for further research in this area.
对于胶质母细胞瘤患者的angiostatin临床试验结果喜忧参半，这强调了该领域需要进一步的研究。
Angiostatin therapy was combined with chemotherapy to improve the outcomes for advanced pancreatic cancer patients.
将angiostatin疗法与化疗结合，以提高晚期胰腺癌患者的结果。
Preclinical studies on angiostatin have revealed its potential in preventing metastasis by disrupting the formation of new blood vessels in tumors.
关于angiostatin的预临床研究表明，它有可能通过破坏肿瘤内的新血管形成来防止转移。
Scientists are exploring the possibility of using angiostatin as a targeted drug delivery system to specifically target cancer cells.
科学家们正在探索使用angiostatin作为靶向药物递送系统，以特异性地针对癌细胞。
Angiostatin's anti-angiogenic properties have sparked interest in its potential role in treating cardiovascular diseases, such as atherosclerosis.
(angiostatin的抗血管生成特性引起了人们对它在治疗心血管疾病（如动脉粥样硬化）中的潜在作用的兴趣。
Researchers have observed that angiostatin can induce apoptosis in cancer cells, contributing to its anti-tumor effects.
研究者发现angiostatin能诱导癌细胞凋亡，从而有助于其抗肿瘤效应。
The development of angiostatin-based therapies is still in its early stages, but preliminary findings offer hope for novel approaches to combat various diseases.
基于angiostatin的疗法仍在早期阶段，但初步发现为对抗各种疾病的新型方法带来了希望。